CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 62 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $132,000 | -57.0% | 52,625 | -49.0% | 0.00% | – |
| Q2 2021 | $307,000 | -28.9% | 103,253 | -16.1% | 0.00% | – |
| Q1 2021 | $432,000 | -17.1% | 123,108 | +12.3% | 0.00% | – |
| Q4 2020 | $521,000 | +11.6% | 109,631 | +13.9% | 0.00% | – |
| Q3 2020 | $467,000 | +56.2% | 96,257 | +4.7% | 0.00% | – |
| Q2 2020 | $299,000 | -52.1% | 91,909 | -24.6% | 0.00% | – |
| Q1 2020 | $624,000 | +12.2% | 121,918 | 0.0% | 0.00% | – |
| Q4 2019 | $556,000 | -21.1% | 121,918 | +5.9% | 0.00% | – |
| Q3 2019 | $705,000 | +10.7% | 115,118 | +10.1% | 0.00% | – |
| Q2 2019 | $637,000 | +9.8% | 104,516 | 0.0% | 0.00% | – |
| Q1 2019 | $580,000 | +16.9% | 104,516 | +19.2% | 0.00% | – |
| Q4 2018 | $496,000 | – | 87,651 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |